Jecure Therapeutics, a San Diego company targeting inflammatory liver diseases, said Tuesday it has agreed to be purchased by Genentech. The purchase price wasn?t disclosed.
Privately held Jecure was founded in 2015 with financing from Versant Ventures. The company raised $20 million from Versant…
